地塞米松预防甲状腺乳头状癌术后恶心呕吐的随机临床试验
这项单中心、平行分组、双盲、安慰剂对照试验纳入600例甲状腺乳头状癌患者,随机分为术前8mg地塞米松组和生理盐水对照组,主要结局为术后恶心呕吐(PONV)的发生率和严重程度。意向性分析显示地塞米松组PONV发生率为27.0%,对照组为39.7%(p=0.001),绝对风险降低12.7%,且不增加不良事件。
要点
- 术前单次8mg地塞米松可降低甲状腺乳头状癌术后PONV发生率。
- 地塞米松组PONV发生率27.0%,对照组39.7%,绝对风险降低12.7%。
- 地塞米松还减轻术后疼痛、改善发音障碍,未增加不良事件。
核心结论
- 术前单次8mg地塞米松可有效且安全地预防甲状腺乳头状癌患者术后恶心呕吐。
研究设计与样本
- 单中心、平行分组、双盲、安慰剂对照随机临床试验,纳入600例甲状腺乳头状癌患者,1:1随机分为地塞米松组(术前8mg)和对照组(0.9% NaCl)。
主要发现
- 意向性分析中,地塞米松组PONV发生81/300例(27.0%;95%CI 21.9-32.1),对照组119/300例(39.7%;95%CI 34.1-45.2),p=0.001。
- 绝对风险降低12.7%(95%CI 5.1-20.0)。
- 地塞米松组需要止吐药的患者少于对照组(p=0.004)。
- 多因素分析显示地塞米松给药与PONV发生率降低相关(OR=0.546;95%CI 0.383-0.777;p=0.001)。
- 地塞米松还减轻术后疼痛、改善主观发音障碍,且未增加不良事件。
临床怎么用
- 对甲状腺乳头状癌行甲状腺切除术的患者,可考虑术前单次给予8mg地塞米松以预防PONV并减轻术后疼痛和发音障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative nausea and vomiting (PONV) frequently occur after thyroidectomy. Previous studies have investigated the effects of preoperative dexamethasone for alleviating PONV in various cancers, but studies focused on papillary thyroid carcinoma (PTC) were limited. This study aimed to determine the efficacy of a single preoperative dose of dexamethasone to prevent PONV in patients with PTC. METHODS: This single-center, parallel-group, double-blind, placebo-controlled clinical trial was conducted on patients with PTC in West China Hospital. Patients were randomized 1:1 into Group Dex (preoperative 8-mg dexamethasone) or Group Control (0.9% NaCl as control). The primary outcome was the incidence and severity of PONV. The secondary outcomes included postoperative pain, vocal dysfunction, and adverse events. RESULTS: Six hundred participants were recruited and randomized. The total incidence of PONV was 33.3% (200 of 600 patients; 95% CI, 29.6-37.1). In the intention-to-treat analysis, PONV occurred in 81 of 300 patients (27.0%; 95% CI, 21.9-32.1) in Group Dex and in 119 of 300 patients (39.7%; 95% CI, 34.1-45.2) in Group Control (p = 0.001), and the absolute risk reduction was 12.7% (95% CI, 5.1-20.0). Patients in Group Dex reported fewer antiemetic requirements than those in Group Control (p = 0.004). Multivariate analysis indicated that dexamethasone administration (OR = 0.546; 95% CI, 0.383-0.777; p = 0.001) was associated with a reduced rate of PONV. Dexamethasone treatment also contributed to alleviating postoperative pain and improving subjective vocal dysfunction, with no increase in adverse events. CONCLUSIONS: A single dose of dexamethasone is effective and safe for preventing PONV in PTC patients.
引用
- Chen W, Li G, Jiang K, et al. Dexamethasone for Postoperative Nausea and Vomiting in Papillary Thyroid Carcinoma Patients: A Randomized Clinical Trial. J Am Coll Surg. 2022. PMID: 35972165. doi:10.1097/XCS.0000000000000309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。